Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RLMDRLMD
5 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in RELMADA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 767,624 shares of RLMD (RELMADA THERAPEUTICS INC), worth $5.3M as of 2026-Q2. The position was increased (+9.8% shares). RLMD represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$5.3M

Current Shares

767,624

Total Value Change

+$5.3M

Total Shares Change

+646,772

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
767,624
+9.8%
$5.3M0.0%$6.92
30
2026-Q1
Increased
699,039
+382.1%
$4.9M0.0%$4.67
43
2025-Q4
New
145,000
-
$700,3500.0%$4.53
34
2025-Q2
Exited
0
-100.0%
$00.0%$0.61
0
2025-Q1
New
120,852
-
$32,6300.0%$0.30
30

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used